1. Long intergenic noncoding RNA 00641 inhibits breast cancer cell proliferation, migration, and invasion by sponging miR‐194‐5p
    Qixin Mao et al, 2020, Journal of Cellular Physiology CrossRef
  2. Therapeutic strategies targeting FOXO transcription factors
    Giampaolo Calissi et al, 2021, Nature Reviews Drug Discovery CrossRef
  3. Zingerone suppresses proliferation, invasion, and migration of hepatocellular carcinoma cells by the inhibition of MTDH-mediated PI3K/Akt pathway
    Jian Fang et al, 2022, Journal of Receptors and Signal Transduction CrossRef
  4. Upregulation of lncRNA CASC2 Suppresses Cell Proliferation and Metastasis of Breast Cancer via Inactivation of the TGF-β Signaling Pathway
    Yang Zhang et al, 2019, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics CrossRef
  5. The Role of lncRNAs in the Distant Metastasis of Breast Cancer
    Yinan Wu et al, 2019, Frontiers in Oncology CrossRef
  6. Histone Modifications and Non-Coding RNAs: Mutual Epigenetic Regulation and Role in Pathogenesis
    Irina V. Bure et al, 2022, International Journal of Molecular Sciences CrossRef
  7. Solamargine inhibits gastric cancer progression by regulating the expression of lncNEAT1_2 via the MAPK signaling pathway
    Runjia Fu et al, 2019, International Journal of Oncology CrossRef
  8. LINC01857 as an oncogene regulates CREB1 activation by interacting with CREBBP in breast cancer
    Youyi Xiong et al, 2019, Journal of Cellular Physiology CrossRef
  9. LncRNA ZEB1-AS1/miR-409–3p/ZEB1 feedback loop is involved in the progression of non-small cell lung cancer
    Ruize Qu et al, 2018, Biochemical and Biophysical Research Communications CrossRef
  10. FoxO transcription factors in cancer metabolism
    Raj Kumar Yadav et al, 2018, Seminars in Cancer Biology CrossRef
  11. The Role of Deubiquitinases in Vascular Diseases
    Biqing Wang et al, 2020, Journal of Cardiovascular Translational Research CrossRef
  12. Coding roles of long non-coding RNAs in breast cancer: Emerging molecular diagnostic biomarkers and potential therapeutic targets with special reference to chemotherapy resistance
    Dharambir Kashyap et al, 2023, Frontiers in Genetics CrossRef
  13. DSCAM‐AS1 promotes tumor growth of breast cancer by reducing miR‐204‐5p and up‐regulating RRM2
    Wen‐Hui Liang et al, 2019, Molecular Carcinogenesis CrossRef
  14. Circulating LncRNAs landscape as potential biomarkers in breast cancer
    Zahra Pourramezan et al, 2023, Cancer Reports CrossRef
  15. Prognostic and predictive value of monocarboxylate transporter 4 in patients with breast cancer
    Sheng Xiao et al, 2020, Oncology Letters CrossRef